scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Seaman, Barrett"

1 - 10 of 514 results for
 "Seaman, Barrett"
Results per page:

Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters

Publication Type: Academic Journal

Source(s): npj Vaccines, Vol 7, Iss 1, Pp 1-6 (2022)

Abstract: Abstract SARS-CoV-2 Spike-specific binding and neutralizing antibodies, elicited either by natural infection or vaccination, have emerged as potential correlates of protection. An important question, however, is whether vaccine-elicited antibodies in h...

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; February 2022, Vol. 399 Issue: 10325 p665-676, 12p

Abstract: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety o...

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; January 2022, Vol. 399 Issue: 10320 p143-151, 9p

Abstract: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p

Abstract: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p

Abstract: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.

Dynamic Prediction of Survival in Cystic Fibrosis: A Landmarking Analysis Using UK Patient Registry Data.

Publication Type: Academic Journal

Source(s): Epidemiology; Jan2019, Vol. 30 Issue 1, p29-37, 9p

Abstract: Copyright of Epidemiology is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, downl...

Under Heavy Fire.

Publication Type: Periodical

Source(s): TIME Magazine; 12/15/1986, Vol. 128 Issue 24, p18-22, 5p, 3 Color Photographs

sponsored